BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30852968)

  • 1. Intravenous Magnesium Sulfate in Acute Stroke.
    Avgerinos KI; Chatzisotiriou A; Haidich AB; Tsapas A; Lioutas VA
    Stroke; 2019 Apr; 50(4):931-938. PubMed ID: 30852968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prehospital use of magnesium sulfate as neuroprotection in acute stroke.
    Saver JL; Starkman S; Eckstein M; Stratton SJ; Pratt FD; Hamilton S; Conwit R; Liebeskind DS; Sung G; Kramer I; Moreau G; Goldweber R; Sanossian N;
    N Engl J Med; 2015 Feb; 372(6):528-36. PubMed ID: 25651247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.
    Muir KW; Lees KR; Ford I; Davis S;
    Lancet; 2004 Feb; 363(9407):439-45. PubMed ID: 14962524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of smoking status on outcome after acute ischemic stroke.
    Ovbiagele B; Weir CJ; Saver JL; Muir KW; Lees KR;
    Cerebrovasc Dis; 2006; 21(4):260-5. PubMed ID: 16446540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NXY-059 for acute ischemic stroke.
    Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
    N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta-analysis of 19 Studies.
    Luo S; Zhuang M; Zeng W; Tao J
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Kumar G; Uhrig D; Fowler S; DeLaney MC; Alexandrov AV
    CNS Drugs; 2015 Aug; 29(8):659-67. PubMed ID: 26251162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular Treatment with Stent-Retriever Devices for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Bush CK; Kurimella D; Cross LJ; Conner KR; Martin-Schild S; He J; Li C; Chen J; Kelly T
    PLoS One; 2016; 11(1):e0147287. PubMed ID: 26807742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline for acute stroke treatment: a systematic review and meta-analysis of randomized clinical trials.
    Malhotra K; Chang JJ; Khunger A; Blacker D; Switzer JA; Goyal N; Hernandez AV; Pasupuleti V; Alexandrov AV; Tsivgoulis G
    J Neurol; 2018 Aug; 265(8):1871-1879. PubMed ID: 29948247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
    Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial.
    Lees KR; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Ashwood T; Hardemark HG; Wasiewski W; Emeribe U; Zivin JA;
    Stroke; 2006 Dec; 37(12):2970-8. PubMed ID: 17068304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke.
    Tsivgoulis G; Kadlecová P; Kobayashi A; Czlonkowska A; Brozman M; Švigelj V; Csiba L; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Katsanos AH; Rudolf J; Krespi Y; Mikulik R
    Stroke; 2015 Sep; 46(9):2681-4. PubMed ID: 26173726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis.
    Sheth KN; Petersen NH; Cheung K; Elm JJ; Hinson HE; Molyneaux BJ; Beslow LA; Sze GK; Simard JM; Kimberly WT
    Stroke; 2018 Jun; 49(6):1457-1463. PubMed ID: 29789393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials.
    Ní Chróinín D; Asplund K; Åsberg S; Callaly E; Cuadrado-Godia E; Díez-Tejedor E; Di Napoli M; Engelter ST; Furie KL; Giannopoulos S; Gotto AM; Hannon N; Jonsson F; Kapral MK; Martí-Fàbregas J; Martínez-Sánchez P; Milionis HJ; Montaner J; Muscari A; Pikija S; Probstfield J; Rost NS; Thrift AG; Vemmos K; Kelly PJ
    Stroke; 2013 Feb; 44(2):448-56. PubMed ID: 23287777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
    Charidimou A; Pasi M; Fiorelli M; Shams S; von Kummer R; Pantoni L; Rost N
    Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiposity and Outcome After Ischemic Stroke: Obesity Paradox for Mortality and Obesity Parabola for Favorable Functional Outcomes.
    Liu Z; Sanossian N; Starkman S; Avila-Rinek G; Eckstein M; Sharma LK; Liebeskind D; Conwit R; Hamilton S; Saver JL;
    Stroke; 2021 Jan; 52(1):144-151. PubMed ID: 33272129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
    Diener HC; Lees KR; Lyden P; Grotta J; Davalos A; Davis SM; Shuaib A; Ashwood T; Wasiewski W; Alderfer V; Hårdemark HG; Rodichok L;
    Stroke; 2008 Jun; 39(6):1751-8. PubMed ID: 18369171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.